Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Positioning of proteasome inhibitors in therapy of solid malignancies.
Cancer Chemother Pharmacol. 2018 Feb;81(2):227-243. doi: 10.1007/s00280-017-3489-0. Epub 2017 Nov 28.
Cancer Chemother Pharmacol. 2018.
PMID: 29184971
Free PMC article.
Review.
Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomib against Bortezomib-Resistant Leukemia Cells and Primary Acute Leukemia Cells.
Roeten MSF, van Meerloo J, Kwidama ZJ, Ter Huizen G, Segerink WH, Zweegman S, Kaspers GJL, Jansen G, Cloos J.
Roeten MSF, et al.
Cells. 2021 Mar 17;10(3):665. doi: 10.3390/cells10030665.
Cells. 2021.
PMID: 33802801
Free PMC article.
Item in Clipboard
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1.
Carbone D, Pecoraro C, Panzeca G, Xu G, Roeten MSF, Cascioferro S, Giovannetti E, Diana P, Parrino B.
Carbone D, et al. Among authors: roeten msf.
Mar Drugs. 2023 Jul 19;21(7):412. doi: 10.3390/md21070412.
Mar Drugs. 2023.
PMID: 37504943
Free PMC article.
Item in Clipboard
Cite
Cite